43 related articles for article (PubMed ID: 12666184)
1. Earlier detection of human immunodeficiency virus type 1 p24 antigen and immunoglobulin G and M antibodies to p17 antigen in seroconversion serum panels by immune complex transfer enzyme immunoassays.
Hashida S; Ishikawa S; Hashinaka K; Nishikata I; Oka S; Ishikawa E
Clin Diagn Lab Immunol; 2000 Nov; 7(6):872-81. PubMed ID: 11063490
[TBL] [Abstract][Full Text] [Related]
2. Parameters influencing measurement of the Gag antigen-specific T-proliferative response to HIV type 1 infection.
Schiller DS; Binley JM; Roux KH; Adamson CS; Jones IM; Krausslich HG; Hurley A; Markowitz M; Moore JP
AIDS Res Hum Retroviruses; 2000 Feb; 16(3):259-71. PubMed ID: 10710214
[TBL] [Abstract][Full Text] [Related]
3. Persistent antibody responses but declining cytotoxic T-lymphocyte responses to multiple human immunodeficiency virus type 1 antigens in a long-term nonprogressing individual with a defective p17 proviral sequence and no detectable viral RNA expression.
Binley JM; Jin X; Huang Y; Zhang L; Cao Y; Ho DD; Moore JP
J Virol; 1998 Apr; 72(4):3472-4. PubMed ID: 9525685
[TBL] [Abstract][Full Text] [Related]
4. Expression of HIV-1 antigens in plants as potential subunit vaccines.
Meyers A; Chakauya E; Shephard E; Tanzer FL; Maclean J; Lynch A; Williamson AL; Rybicki EP
BMC Biotechnol; 2008 Jun; 8():53. PubMed ID: 18573204
[TBL] [Abstract][Full Text] [Related]
5. HIV p17 enhances T cell proliferation by suppressing autophagy through the p17-OLA1-GSK3β axis under nutrient starvation.
Lu J; Jia J; Zhang J; Liu X
J Med Virol; 2021 Jun; 93(6):3607-3620. PubMed ID: 32790080
[TBL] [Abstract][Full Text] [Related]
6. Engineered CD4 T cells expressing a membrane anchored viral inhibitor restrict HIV-1 through
Wang W; Truong K; Ye C; Sharma S; He H; Liu L; Wen M; Misra A; Zhou P; Kimata JT
Front Immunol; 2023; 14():1167965. PubMed ID: 37781368
[TBL] [Abstract][Full Text] [Related]
7. Total chemical synthesis of N-myristoylated HIV-1 matrix protein p17: structural and mechanistic implications of p17 myristoylation.
Wu Z; Alexandratos J; Ericksen B; Lubkowski J; Gallo RC; Lu W
Proc Natl Acad Sci U S A; 2004 Aug; 101(32):11587-92. PubMed ID: 15280532
[TBL] [Abstract][Full Text] [Related]
8. Interleukin 2-inducible T cell kinase (ITK) facilitates efficient egress of HIV-1 by coordinating Gag distribution and actin organization.
Schiralli Lester GM; Akiyama H; Evans E; Singh J; Gummuluru S; Henderson AJ
Virology; 2013 Feb; 436(1):235-43. PubMed ID: 23260110
[TBL] [Abstract][Full Text] [Related]
9. Detection of HIV-1 matrix protein p17 in sera of viremic and aviremic patients.
Zani A; Messali S; Uggeri M; Bonfanti C; Caruso A; Caccuri F
J Virol Methods; 2024 Feb; 324():114858. PubMed ID: 38029970
[TBL] [Abstract][Full Text] [Related]
10. The HIV-1 Matrix Protein p17 Does Cross the Blood-Brain Barrier.
Caccuri F; Neves V; Gano L; Correia JDG; Oliveira MC; Mazzuca P; Caruso A; Castanho M
J Virol; 2022 Jan; 96(1):e0120021. PubMed ID: 34668776
[TBL] [Abstract][Full Text] [Related]
11. Modulated expression of the HIV-1 2LTR zinc finger efficiently interferes with the HIV integration process.
Moonmuang S; Saoin S; Chupradit K; Sakkhachornphop S; Israsena N; Rungsiwiwut R; Tayapiwatana C
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30068696
[TBL] [Abstract][Full Text] [Related]
12. Zinc finger protein designed to target 2-long terminal repeat junctions interferes with human immunodeficiency virus integration.
Sakkhachornphop S; Barbas CF; Keawvichit R; Wongworapat K; Tayapiwatana C
Hum Gene Ther; 2012 Sep; 23(9):932-42. PubMed ID: 22429108
[TBL] [Abstract][Full Text] [Related]
13. Nanotools for megaproblems: probing protein misfolding diseases using nanomedicine modus operandi.
Uversky VN; Kabanov AV; Lyubchenko YL
J Proteome Res; 2006 Oct; 5(10):2505-22. PubMed ID: 17022621
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of HIV-1 replication in primary human T cells transduced with an intracellular anti-HIV-1 p17 antibody gene.
Tewari D; Notkins AL; Zhou P
J Gene Med; 2003 Mar; 5(3):182-9. PubMed ID: 12666184
[TBL] [Abstract][Full Text] [Related]
15. cDNA encoding a single-chain antibody to HIV p17 with cytoplasmic or nuclear retention signals inhibits HIV-1 replication.
Tewari D; Goldstein SL; Notkins AL; Zhou P
J Immunol; 1998 Sep; 161(5):2642-7. PubMed ID: 9725267
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens.
Kmieciak D; Bolesta E; Naito T; Gzyl J; Kaneko Y; Kozbor D
J Hum Virol; 2001; 4(6):306-16. PubMed ID: 12082397
[TBL] [Abstract][Full Text] [Related]
17. Immunization of human HIV-seronegative volunteers with recombinant p17/p24:Ty virus-like particles elicits HIV-1 p24-specific cellular and humoral immune responses.
Martin SJ; Vyakarnam A; Cheingsong-Popov R; Callow D; Jones KL; Senior JM; Adams SE; Kingsman AJ; Matear P; Gotch FM
AIDS; 1993 Oct; 7(10):1315-23. PubMed ID: 8267904
[TBL] [Abstract][Full Text] [Related]
18. Functions of the HIV-1 matrix protein p17.
Fiorentini S; Marini E; Caracciolo S; Caruso A
New Microbiol; 2006 Jan; 29(1):1-10. PubMed ID: 16608119
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
